 Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of MEI Pharma, Inc. NASDAQ: MEIP between August 2, 2017 and July 1, 2020, inclusive the Class Period. The lawsuit seeks to recover damages for MEI Pharma investors under the federal securities laws. 